Capitol Health (ASX:CAJ) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

CAJ Aktienübersicht

Capitol Health Limited bietet diagnostische Bildgebungsmodalitäten und damit verbundene Dienstleistungen für den Gesundheitsmarkt in Australien an.

Über das Unternehmen

CAJ fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	2/6
Financial Health	1/6
Dividends	2/6

Belohnungen

14.1% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 39.1% pro Jahr

In diesem Jahr profitabel geworden

Risikoanalyse

Zinszahlungen sind nicht ausreichend durch Erträge gedeckt

Die Dividende von 4% ist nicht ausreichend durch Gewinne oder Cashflows gedeckt.

Große einmalige Posten, die sich auf die Finanzergebnisse auswirken

Capitol Health Limited Wettbewerber

Healthia

ASX:HLA

AU$252.1m

Australian Clinical Labs

ASX:ACL

AU$441.1m

SILK Laser Australia

ASX:SLA

AU$177.4m

Apiam Animal Health

ASX:AHX

AU$66.2m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Capitol Health
Historical stock prices
Current Share Price	AU$0.24
52 Week High	AU$0.29
52 Week Low	AU$0.18
Beta	0.67
1 Month Change	0%
3 Month Change	-12.73%
1 Year Change	-15.79%
3 Year Change	-33.33%
5 Year Change	0%
Change since IPO	-9.43%

Aktuelle Nachrichten und Updates

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Aktionärsrenditen

	CAJ	AU Healthcare	AU Markt
7D	-4.0%	-2.3%	-2.2%
1Y	-15.8%	-23.3%	8.8%

Rendite im Vergleich zur Industrie: CAJ übertraf die Branche Australian Healthcare, die im vergangenen Jahr eine Rendite von -20.9 erzielte.

Rendite vs. Markt: CAJ hinter dem Markt Australian zurück, der im vergangenen Jahr eine Rendite von 8.8 erzielte.

Preisvolatilität

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	6.0%
Healthcare Industry Average Movement	6.0%
Market Average Movement	8.8%
10% most volatile stocks in AU Market	17.2%
10% least volatile stocks in AU Market	3.3%

Stabiler Aktienkurs: CAJ hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: CAJDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited stellt diagnostische Bildgebungsmodalitäten und damit verbundene Dienstleistungen für den Gesundheitsmarkt in Australien bereit. Das Unternehmen bietet eine Reihe von diagnostischen Bildgebungsdiensten an, darunter allgemeines Röntgen, Magnetresonanztomographie, Ultraschall, Mammographie, Doppler, Orthopantomographie, Echokardiographie, Computertomographie, CT-Angiographie, Kegelstrahl-CT, Nuklearmedizin, Knochendichtemessung und Fluoroskopie. Es betreibt verschiedene Kliniken in Victoria, Tasmanien, Westaustralien und Südaustralien unter der Marke Capital Radiology sowie unter den Markennamen Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology und Future Medical Imaging Group.

Capitol Health Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Capitol Health im Vergleich zum Marktanteil des Unternehmens?
CAJ grundlegende Statistiken
Marktanteil	AU$255.70m
Gewinn(TTM)	AU$6.14m
Umsatz(TTM)	AU$229.29m

41.6x

Kurs-Gewinn-Verhältnis

1.1x

Kurs-Umsatz-Verhältnis

Ist CAJ zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CAJ Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$229.29m
Kosten der Einnahmen	AU$178.18m
Bruttogewinn	AU$51.11m
Sonstige Ausgaben	AU$44.97m
Umsatz	AU$6.14m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.0058
Bruttomarge	22.29%
Nettogewinnspanne	2.68%
Schulden/Eigenkapital-Verhältnis	62.0%

Wie hat sich CAJ auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

4.2%

Aktuelle Dividendenrendite

173%

Ausschüttungsquote

CAJ Aktienübersicht

Belohnungen

Risikoanalyse

Capitol Health Limited Wettbewerber

ASX:HLA

AU$252.1m

ASX:ACL

AU$441.1m

ASX:SLA

AU$177.4m

ASX:AHX

AU$66.2m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Recent updates

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

Erträge & Einnahmen